IMA
ImageneBio, Inc.
+0.32 (+6.49%)5.25USD12.1K成交股數59.6M市值–本益比(近四季)74.5股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00-100% | – | 800K | – | 3.5M+75% | – | – | 1.2M | 2.0M | 5.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.7M | 6.0M | 15.6M | 5.7M | 4.0M | 8.7M | 3.9M | 9.8M | 9.6M | 14.7M | 15.2M | 15.6M |
| 銷售管理費用 | 5.1M | 6.1M | 11.0M | 1.7M | 2.8M | −4.6M | 1.7M | 5.3M | 6.0M | 6.0M | 5.3M | 5.3M |
| 營業利益 | −11.8M+97% | −12.1M+1220% | −26.6M+1206% | −7.4M-53% | −6.0M-67% | −915K-95% | −2.0M-89% | −15.8M+2% | −18.2M | −19.5M | −18.5M | −15.5M |
| 營業利益率 | – | – | – | – | -749.4% | – | -58.2% | – | – | -1,645.8% | -922.7% | -292.0% |
| 稅後淨利 | −10.2M+67% | −10.6M+121% | −24.8M+678% | −7.6M+21% | −6.1M-73% | −4.8M-72% | −3.2M-81% | −6.3M-56% | −22.3M | −17.3M | −17.1M | −14.2M |
| 淨利率 | – | – | – | – | -759.6% | – | -90.9% | – | – | -1,463.5% | -854.0% | -267.6% |
| 稀釋 EPS | -0.63-83% | -0.95-95% | -2.91+13% | -4.46+1493% | -3.80+1052% | -18.91+4628% | -2.58+486% | -0.28-28% | -0.33 | -0.40 | -0.44 | -0.39 |
| 稀釋股數 | 16.2M | 11.2M | – | 2.4M | 2.4M | 48.3M | 48.3M | 48.3M | 48.3M | 43.4M | 39.3M | 36.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 94.7M | 76.0M | 103M | 58.3M | 36.8M | 12.1M | 45.2M | 44.3M | 52.9M | 121M | 70.9M | 29.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 152M | 137M | 161M | 126M | 131M | 15.9M | 149M | 157M | 173M | 215M | 172M | 152M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.0M | 13.4M | 21.0M | 10.3M | 12.6M | 17.4M | 14.8M | 14.6M | 17.4M | 28.1M | 15.1M | 17.4M |
| 股東權益 | 142M | 123M | 140M | −180M | −170M | −161M | −153M | −147M | −137M | 155M | 157M | 135M |
| 負債比 | 6.6% | 9.8% | 13.1% | 8.1% | 9.6% | 109.6% | 9.9% | 9.3% | 10.1% | 13.1% | 8.8% | 11.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −14.8M | – | – | −7.2M-61% | – | – | – | −18.3M | – | – | −19.8M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 152K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −19.9M |
| 折舊攤銷 | – | 0.00 | – | – | 2K | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | -375.2% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 800K | -77.1% | −45.3M | -5,668.6% | -9.64 | – |
| FY2024 | 3.5M | -61.8% | −36.6M | -1,044.8% | -22.10 | – |
| FY2023 | 9.2M | -41.3% | −68.2M | -744.2% | -1.63 | −80.2M |
| FY2022 | 15.6M | -49.6% | −68.8M | -440.3% | -1.90 | −75.5M |
| FY2021 | 31.0M | +237.0% | −34.1M | -110.1% | -1.22 | −62.0M |
| FY2020 | 9.2M | – | −44.3M | -481.4% | -16.00 | −38.6M |